Role of major histocompatibility complex class II expression by non-hematopoietic cells in autoimmune and inflammatory disorders: Facts and fiction

Tissue Antigens

Volumn 82, Issue 1, 2013, Pages 1-15

  Duraes, F V ^a   Thelemann, C ^b   Sarter, K ^a   Acha Orbea, H ^b   Hugues, S ^a   Reith, W ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Antigen presentation; Autoimmunity; Inflammation; Major histocompatibility complex class II; Non professional antigen presenting cells

Indexed keywords

GAMMA INTERFERON; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEAR FACTOR Y;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; CD4+ T LYMPHOCYTE; ENHANCER REGION; ENTERITIS; GENE DELETION; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MYOCARDITIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; THYROIDITIS;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HEMATOPOIETIC SYSTEM; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFLAMMATION; ORGAN SPECIFICITY;

EID: 84879777655     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12136     Document Type: Review

References (121)

1. Guardiola J, Maffei A. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit Rev Immunol 1993: 13: 247-68.
2. Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 2005: 5: 793-806.
3. Kobayashi KS, Van den Elsen PJ. NLRC5: a key regulator of MHC class I-dependent immune responses. Nat Rev Immunol 2012: 12: 813-20.
4. Waldburger JM, Suter T, Fontana A, Acha-Orbea H, Reith W. Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med 2001: 194: 393-406.
5. Waldburger JM, Rossi S, Hollander GA, Rodewald HR, Reith W, Acha-Orbea H. Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells. Blood 2003: 101: 3550-9.
6. Irla M, Hugues S, Gill J et al. Autoantigen-specific interactions with CD4+ thymocytes control mature medullary thymic epithelial cell cellularity. Immunity 2008: 29: 451-63.
7. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003: 3: 331-41.
8. Meresse B, Malamut G, Cerf-Bensussan N. Celiac disease: an immunological jigsaw. Immunity 2012: 36: 907-19.
9. Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 1995: 37: 766-76.
10. Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007: 102: 2058-69.
11. Ciccocioppo R, Di Sabatino A, Corazza GR. The immune recognition of gluten in coeliac disease. Clin Exp Immunol 2005: 140: 408-16.
12. Zimmer KP, Poremba C, Weber P, Ciclitira PJ, Harms E. Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes. Gut 1995: 36: 703-9.
13. Li XC, Almawi W, Jevnikar A, Tucker J, Zhong R, Grant D. Allogeneic lymphocyte proliferation stimulated by small intestine-derived epithelial cells. Transplantation 1995: 60: 82-9.
14. Hoang P, Crotty B, Dalton HR, Jewell DP. Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes. Gut 1992: 33: 1089-93.
15. Cruickshank SM, McVay LD, Baumgart DC, Felsburg PJ, Carding SR. Colonic epithelial cell mediated suppression of CD4 T cell activation. Gut 2004: 53: 678-84.
16. Byrne B, Madrigal-Estebas L, McEvoy A et al. Human duodenal epithelial cells constitutively express molecular components of antigen presentation but not costimulatory molecules. Hum Immunol 2002: 63: 977-86.
17. Bloom S, Simmons D, Jewell DP. Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin Exp Immunol 1995: 101: 157-63.
18. Sanderson IR, Ouellette AJ, Carter EA, Walker WA, Harmatz PR. Differential regulation of B7 mRNA in enterocytes and lymphoid cells. Immunology 1993: 79: 434-8.
19. Borcherding F, Nitschke M, Hundorfean G et al. The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease. Am J Pathol 2010: 176: 1816-27.
20. Dotan I, Allez M, Nakazawa A, Brimnes J, Schulder-Katz M, Mayer L. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol 2007: 292: G1630-40.
21. Nakazawa A, Watanabe M, Kanai T et al. Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa. Gastroenterology 1999: 117: 536-45.
22. Maggio-Price L, Seamons A, Bielefeldt-Ohmann H et al. Lineage targeted MHC-II transgenic mice demonstrate the role of dendritic cells in bacterial-driven colitis. Inflamm Bowel Dis 2013: 19: 174-84.
23. Kaiserlian D, Vidal K, Revillard JP. Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells. Eur J Immunol 1989: 19: 1513-6.
24. Schmitz H, Barmeyer C, Fromm M et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 1999: 116: 301-9.
25. Henderson P, van Limbergen JE, Schwarze J, Wilson DC. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease. Inflamm Bowel Dis 2011: 17: 382-95.
26. Framson PE, Cho DH, Lee LY, Hershberg RM. Polarized expression and function of the costimulatory molecule CD58 on human intestinal epithelial cells. Gastroenterology 1999: 116: 1054-62.
27. Nakazawa A, Dotan I, Brimnes J et al. The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology 2004: 126: 1347-57.
28. Westendorf AM, Fleissner D, Groebe L et al. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells. Gut 2009: 58: 211-9.
29. Powell DW, Pinchuk IV, Saada JI, Chen X, Mifflin RC. Mesenchymal cells of the intestinal lamina propria. Annu Rev Physiol 2011: 73: 213-37.
30. Liberal R, Longhi MS, Mieli-Vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2011: 25: 653-64.
31. Oliveira LC, Porta G, Marin ML, Bittencourt PL, Kalil J, Goldberg AC. Autoimmune hepatitis, HLA and extended haplotypes. Autoimmun Rev 2011: 10: 189-93.
32. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006: 43: S54-62.
33. Toyonaga T, Hino O, Sugai S et al. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci U S A 1994: 91: 614-8.
34. Herkel J, Jagemann B, Wiegard C et al. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes. Hepatology 2003: 37: 1079-85.
35. Wiegard C, Wolint P, Frenzel C et al. Defective T helper response of hepatocyte-stimulated CD4 T cells impairs antiviral CD8 response and viral clearance. Gastroenterology 2007: 133: 2010-8.
36. Lohse AW, Knolle PA, Bilo K et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996: 110: 1175-81.
37. Limmer A, Knolle PA. Liver sinusoidal endothelial cells: a new type of organ-resident antigen-presenting cell. Arch Immunol Ther Exp (Warsz) 2001: 49 (Suppl 1): S7-11.
38. Knolle PA, Schmitt E, Jin S et al. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 1999: 116: 1428-40.
39. Knolle PA, Uhrig A, Hegenbarth S et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 1998: 114: 427-33.
40. Katz SC, Pillarisetty VG, Bleier JI, Shah AB, DeMatteo RP. Liver sinusoidal endothelial cells are insufficient to activate T cells. J Immunol 2004: 173: 230-5.
41. Kruse N, Neumann K, Schrage A et al. Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3- regulatory T cells suppressing autoimmune hepatitis. Hepatology 2009: 50: 1904-13.
42. Winau F, Hegasy G, Weiskirchen R et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007: 26: 117-29.
43. Chen CH, Kuo LM, Chang Y et al. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 2006: 44: 1171-81.
44. Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008: 8: 142-52.
45. Jindal SK, Agarwal R. Autoimmunity and interstitial lung disease. Curr Opin Pulm Med 2005: 11: 438-46.
46. Shum AK, DeVoss J, Tan CL et al. Identification of an autoantigen demonstrates a link between interstitial lung disease and a defect in central tolerance. Sci Transl Med 2009: 1: 9ra20.
47. Kreisel D, Richardson SB, Li W et al. Cutting edge: MHC class II expression by pulmonary nonhematopoietic cells plays a critical role in controlling local inflammatory responses. J Immunol 2010: 185: 3809-13.
48. Holt PG. Regulation of antigen-presenting cell function(s) in lung and airway tissues. Eur Respir J 1993: 6: 120-9.
49. Mezzetti M, Soloperto M, Fasoli A, Mattoli S. Human bronchial epithelial cells modulate CD3 and mitogen-induced DNA synthesis in T cells but function poorly as antigen-presenting cells compared to pulmonary macrophages. J Allergy Clin Immunol 1991: 87: 930-8.
50. Paine R 3rd, Mody CH, Chavis A, Spahr MA, Turka LA, Toews GB. Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation. Am J Respir Cell Mol Biol 1991: 5: 221-9.
51. Barnes PJ. Pathophysiology of allergic inflammation. Immunol Rev 2011: 242: 31-50.
52. Oei E, Kalb T, Beuria P et al. Accessory cell function of airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2004: 287: L318-31.
53. Liu C, Qin X, Liu H, Xiang Y. Downregulation of integrin beta4 decreases the ability of airway epithelial cells to present antigens. PLoS One 2012: 7: e32060.
54. Phipps RP, Penney DP, Keng P et al. Characterization of two major populations of lung fibroblasts: distinguishing morphology and discordant display of Thy 1 and class II MHC. Am J Respir Cell Mol Biol 1989: 1: 65-74.
55. Haskins K, Cooke A. CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes. Curr Opin Immunol 2011: 23: 739-45.
56. Eringsmark Regnell S, Lernmark A. The environment and the origins of islet autoimmunity and Type 1 diabetes. Diabet Med 2013: 30: 155-60.
57. Rossini AA, Mordes JP, Like AA. Immunology of insulin-dependent diabetes mellitus. Annu Rev Immunol 1985: 3: 289-320.
58. Liu J, Purdy LE, Rabinovitch S, Jevnikar AM, Elliott JF. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes 1999: 48: 469-77.
59. Guerder S, Picarella DE, Linsley PS, Flavell RA. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc Natl Acad Sci U S A 1994: 91: 5138-42.
60. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985: 313: 353-60.
61. Walter U, Toepfer T, Dittmar KE et al. Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes. Diabetologia 2003: 46: 1106-14.
62. Pujol-Borrell R, Todd I, Doshi M et al. HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature 1987: 326: 304-6.
63. Campbell IL, Oxbrow L, Koulmanda M, Harrison LC. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol 1988: 140: 1111-6.
64. Walker R, Cooke A, Bone AJ, Dean BM, van der Meide P, Baird JD. Induction of class II MHC antigens in vitro on pancreatic B cells isolated from BB/E rats. Diabetologia 1986: 29: 749-51.
65. Lo D, Burkly LC, Widera G et al. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 1988: 53: 159-68.
66. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988: 52: 773-82.
67. Markmann J, Lo D, Naji A, Palmiter RD, Brinster RL, Heber-Katz E. Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature 1988: 336: 476-9.
68. Bohme J, Haskins K, Stecha P et al. Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant. Science 1989: 244: 1179-83.
69. Wong FS, Du W, Thomas IJ, Wen L. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice. Diabetes 2005: 54: 2032-40.
70. Codarri L, Greter M, Becher B. Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease. Trends Immunol 2013: 34: 114-9.
71. Heppner FL, Greter M, Marino D et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 2005: 11: 146-52.
72. Fontana A, Fierz W, Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984: 307: 273-6.
73. Zeinstra E, Wilczak N, Streefland C, De Keyser J. Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport 2000: 11: 89-91.
74. Sedgwick JD, Mossner R, Schwender S, ter Meulen V. Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system. J Exp Med 1991: 173: 1235-46.
75. Kort JJ, Kawamura K, Fugger L, Weissert R, Forsthuber TG. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice. J Neuroimmunol 2006: 173: 23-34.
76. Zeinstra E, Wilczak N, De Keyser J. Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2. J Neuroimmunol 2003: 135: 166-71.
77. Traugott U, Lebon P. Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J Neurol Sci 1988: 84: 257-64.
78. Boyle EA, McGeer PL. Cellular immune response in multiple sclerosis plaques. Am J Pathol 1990: 137: 575-84.
79. Bo L, Mork S, Kong PA, Nyland H, Pardo CA, Trapp BD. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994: 51: 135-46.
80. Horwitz MS, Evans CF, Klier FG, Oldstone MB. Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the the central nervous system: astrocytes fail to express major histocompatibility complex class I and II molecules. Lab Invest 1999: 79: 235-42.
81. Stuve O, Youssef S, Slavin AJ et al. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J Immunol 2002: 169: 6720-32.
82. Fabry Z, Sandor M, Gajewski TF et al. Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. J Immunol 1993: 151: 38-47.
83. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996: 85: 307-10.
84. Lally F, Smith E, Filer A et al. A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis Rheum 2005: 52: 3460-9.
85. Burmester GR, Jahn B, Rohwer P, Zacher J, Winchester RJ, Kalden JR. Differential expression of Ia antigens by rheumatoid synovial lining cells. J Clin Invest 1987: 80: 595-604.
86. Amento EP, Bhan AK, McCullagh KG, Krane SM. Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. J Clin Invest 1985: 76: 837-48.
87. Duke O, Gordon Y, Panayi GS. Synovial fluid mononuclear cells exhibit a spontaneous HLA-DR driven proliferative response. Clin Exp Immunol 1987: 70: 10-7.
88. Tran CN, Davis MJ, Tesmer LA et al. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. Arthritis Rheum 2007: 56: 1497-506.
89. Tran CN, Thacker SG, Louie DM et al. Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3. J Immunol 2008: 180: 2989-98.
90. Poulter LW, Seymour GJ, Duke O, Janossy G, Panayi G. Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol 1982: 74: 358-69.
91. Kanazawa S, Ota S, Sekine C et al. Aberrant MHC class II expression in mouse joints leads to arthritis with extraarticular manifestations similar to rheumatoid arthritis. Proc Natl Acad Sci U S A 2006: 103: 14465-70.
92. Waldburger JM, Palmer G, Seemayer C et al. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis. Arthritis Rheum 2011: 63: 3354-63.
93. Corrigall VM, Solau-Gervais E, Panayi GS. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes. Arthritis Rheum 2000: 43: 1606-15.
94. Leuschner F, Katus HA, Kaya Z. Autoimmune myocarditis: past, present and future. J Autoimmun 2009: 33: 282-9.
95. Caforio AL, Stewart JT, Bonifacio E et al. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J Autoimmun 1990: 3: 187-200.
96. Hufnagel G, Maisch B. Expression of MHC class I and II antigens and the Il-2 receptor in rejection, myocarditis and dilated cardiomyopathy. Eur Heart J 1991: 12 (Suppl D): 137-40.
97. Li WM, Liu W, Gao C, Zhou BG. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats. Immunol Cell Biol 2006: 84: 274-80.
98. Cai G, Zhang J, Liu L, Shen Q. Successful treatment of experimental autoimmune myocarditis by adenovirus-mediated gene transfer of antisense CIITA. J Mol Cell Cardiol 2005: 38: 593-605.
99. Hagerty DT, Evavold BD, Allen PM. Regulation of the costimulator B7, not class II major histocompatibility complex, restricts the ability of murine kidney tubule cells to stimulate CD4+ T cells. J Clin Invest 1994: 93: 1208-15.
100. Mayrhofer G, Schon-Hegrad MA. Ia antigens in rat kidney, with special reference to their expression in tubular epithelium. J Exp Med 1983: 157: 2097-109.
101. Muczynski KA, Ekle DM, Coder DM, Anderson SK. Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol 2003: 14: 1336-48.
102. Jevnikar AM, Grusby MJ, Glimcher LH. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med 1994: 179: 1137-43.
103. Hagerty DT, Allen PM. Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol 1992: 148: 2324-30.
104. Takei Y, Sims TN, Urmson J, Halloran PF. Central role for interferon-gamma receptor in the regulation of renal MHC expression. J Am Soc Nephrol 2000: 11: 250-61.
105. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J Immunol 1997: 158: 4260-9.
106. Xi H, Goodwin B, Shepherd AT, Blanck G. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2. Oncogene 2001: 20: 4219-27.
107. Martin M, Schwinzer R, Schellekens H, Resch K. Glomerular mesangial cells in local inflammation. Induction of the expression of MHC class II antigens by IFN-gamma. J Immunol 1989: 142: 1887-94.
108. Yang WS, Han NJ, Kim CS et al. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells. Nephron Exp Nephrol 2005: 100: e124-31.
109. Radeke HH, Emmendorffer A, Uciechowski P, von der Ohe J, Schwinzer B, Resch K. Activation of autoreactive T-lymphocytes by cultured syngeneic glomerular mesangial cells. Kidney Int 1994: 45: 763-74.
110. Yokoyama H, Takaeda M, Wada T et al. Intraglomerular expression of MHC class II and Ki-67 antigens and serum gamma-interferon levels in IgA nephropathy. Nephron 1992: 62: 169-75.
111. Mukherjee R, Zhang Z, Zhong R, Yin ZQ, Roopenian DC, Jevnikar AM. Lupus nephritis in the absence of renal major histocompatibility complex class I and class II molecules. J Am Soc Nephrol 1996: 7: 2445-52.
112. Li S, Kurts C, Kontgen F, Holdsworth SR, Tipping PG. Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J Exp Med 1998: 188: 597-602.
113. Schnizlein CT, Kosco MH, Szakal AK, Tew JG. Follicular dendritic cells in suspension: identification, enrichment, and initial characterization indicating immune complex trapping and lack of adherence and phagocytic activity. J Immunol 1985: 134: 1360-8.
114. Turley SJ, Fletcher AL, Elpek KG. The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat Rev Immunol 2010: 10: 813-25.
115. Fletcher AL, Lukacs-Kornek V, Reynoso ED et al. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J Exp Med 2010: 207: 689-97.
116. Cohen JN, Guidi CJ, Tewalt EF et al. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med 2010: 207: 681-8.
117. Gardner JM, Devoss JJ, Friedman RS et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 2008: 321: 843-7.
118. Lee JW, Epardaud M, Sun J et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol 2007: 8: 181-90.
119. Malhotra D, Fletcher AL, Astarita J et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol 2012: 13: 499-510.
120. Mueller SN, Matloubian M, Clemens DM et al. Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection. Proc Natl Acad Sci U S A 2007: 104: 15430-5.
121. Onder L, Scandella E, Chai Q et al. A novel bacterial artificial chromosome-transgenic podoplanin-cre mouse targets lymphoid organ stromal cells in vivo. Front Immunol 2011: 2: 50.